HOUSE 990116th CongressReferred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Hatch-Waxman Integrity Act of 2019
- Last Action
- 2/6/2019
CRS Summary
As of 2019-02-06 (00)
Hatch-Waxman Integrity Act of 2019
This bill establishes certain limits on the filing of patent validity challenges with the Patent Trial and Appeal Board, particularly with respect to inter partes review.
Subjects
- Administrative remedies
- Drug safety, medical device, and laboratory regulation
- Fraud offenses and financial crimes
- Intellectual property
- Licensing and registrations
- Prescription drugs
- Securities
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.